Your browser doesn't support javascript.
loading
Neuraminidase inhibitor susceptibility and evolutionary analysis of human influenza B isolates from three Asian countries during 2012-2015.
Hibino, Akinobu; Massaad, Elie; Kondo, Hiroki; Saito, Reiko; Odagiri, Takashi; Takemae, Nobuhiro; Tsunekuni, Ryota; Saito, Takehiko; Kyaw, Yadanar; Lin, Nay; Myint, Yi Yi; Tin, Htay Htay; Le Khanh Hang, Nguyen; Mai, Le Quynh; Yagami, Ren; Shobugawa, Yugo; Lam, Tommy; Zaraket, Hassan.
Affiliation
  • Hibino A; Division of International Health (Public Health), Graduate School of Medical and Dental Sciences, Niigata University, Japan; Department of Pathology, Immunology, and Microbiology, Faculty of Medicine American University of Beirut, Lebanon.
  • Massaad E; Department of Pathology, Immunology, and Microbiology, Faculty of Medicine American University of Beirut, Lebanon; Center for Infectious Disease Research, Faculty of Medicine American University of Beirut, Beirut, Lebanon.
  • Kondo H; Division of International Health (Public Health), Graduate School of Medical and Dental Sciences, Niigata University, Japan.
  • Saito R; Division of International Health (Public Health), Graduate School of Medical and Dental Sciences, Niigata University, Japan. Electronic address: jasmine@med.niigata-u.ac.jp.
  • Odagiri T; Division of International Health (Public Health), Graduate School of Medical and Dental Sciences, Niigata University, Japan.
  • Takemae N; Influenza and Prion Disease Research Center, National Institute of Animal Health, National Agriculture and Food Research Organization (NARO), Ibaraki, Japan.
  • Tsunekuni R; Influenza and Prion Disease Research Center, National Institute of Animal Health, National Agriculture and Food Research Organization (NARO), Ibaraki, Japan.
  • Saito T; Influenza and Prion Disease Research Center, National Institute of Animal Health, National Agriculture and Food Research Organization (NARO), Ibaraki, Japan.
  • Kyaw Y; Respiratory Medicine Department, Sanpya Hospital, Kyaikkasan Pagoda Road, Yangon, Myanmar.
  • Lin N; Clinical Laboratory, Microbiology Section, Pyinmana Township Hospital, Naw Pyi Taw, Myanmar.
  • Myint YY; Ministry of Health and Sports, Department traditional Medicine, Naw Pyi Taw, Myanmar.
  • Tin HH; Ministry of Health and Sports, Department traditional Medicine, Naw Pyi Taw, Myanmar; National Health Laboratory, Ministry of Health and Sports, Yangon, Myanmar.
  • Le Khanh Hang N; National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam.
  • Mai LQ; National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam.
  • Yagami R; Center for Infectious Disease Research, Faculty of Medicine American University of Beirut, Beirut, Lebanon.
  • Shobugawa Y; Center for Infectious Disease Research, Faculty of Medicine American University of Beirut, Beirut, Lebanon.
  • Lam T; School of Public Health, the University of Hong Kong, Hong Kong, China.
  • Zaraket H; Department of Pathology, Immunology, and Microbiology, Faculty of Medicine American University of Beirut, Lebanon; Center for Infectious Disease Research, Faculty of Medicine American University of Beirut, Beirut, Lebanon. Electronic address: hz34@aub.edu.lb.
Infect Genet Evol ; 62: 27-33, 2018 08.
Article in En | MEDLINE | ID: mdl-29665435

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Antiviral Agents / Influenza B virus / Neuraminidase Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Infect Genet Evol Year: 2018 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Antiviral Agents / Influenza B virus / Neuraminidase Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Infect Genet Evol Year: 2018 Document type: Article